MitoKATP channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism

Cardiovasc Res. 2006 May 1;70(2):374-83. doi: 10.1016/j.cardiores.2006.01.023. Epub 2006 Mar 9.

Abstract

Background: Ischemic preconditioning accelerates suppression of gap junction (GJ) permeability during myocardial ischemia, and GJ blockers reduce infarct size. We hypothesized that the mitochondrial ATP-sensitive K+ (mitoKATP) channel is one of the mechanisms regulating GJ permeability through the mitogen-activated protein kinase ERK, leading to cardioprotection.

Methods and results: In isolated rabbit hearts, tissues were sampled before and after infusion of diazoxide, a selective mitoKATP channel opener, and their intercalated disc-rich fractions were obtained for immunoblotting of mitogen-activated protein kinases. GJ permeability in the myocardium was assessed by using Lucifer yellow as a tracer of GJ communication. Infarction was induced by 30-min global ischemia/2 h reperfusion, and infarct size was expressed as a percent of area-at-risk (%IS/AR). Diazoxide (100 microM) induced phosphorylation of ERK1/2 and 279Ser/282Ser of connexin-43, a GJ subunit protein, and phospho-ERK1/2 was co-immunoprecipitated with connexin-43 in the diazoxide-treated myocardium. This ERK1/2 phosphorylation by diazoxide was inhibited by N-2-mercaptopropionyl-glycine, a free radical scavenger. Diazoxide at 10 and 100 microM reduced intercellular transport of Lucifer yellow during ischemia by 44% and 69%, respectively, and this effect of diazoxide on GJ communication was abolished by PD98059, an ERK inhibitor. Pretreatment with 10 microM and 100 microM diazoxide reduced %IS/AR from 57.1+/-3.7% to 21.5+/-10.5% and 5.0+/-1.3%, respectively. PD98059 abolished cardioprotection by 10 microM diazoxide but not that by 100 microM diazoxide.

Conclusions: Opening of the mitoKATP channel activates ERK1/2 via free radicals and induces ERK-mediated suppression of GJ permeability. This suppression of GJ permeability may partly contribute to cardioprotection afforded by mitoKATP channel activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Animals
  • Cell Membrane Permeability / drug effects
  • Connexin 43 / metabolism
  • Diazoxide / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Free Radical Scavengers / pharmacology
  • Gap Junctions / metabolism*
  • Immunoblotting
  • Immunoprecipitation
  • MAP Kinase Signaling System
  • Mitochondria, Heart / enzymology*
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / metabolism*
  • Myocardial Ischemia / metabolism*
  • Myocardial Ischemia / pathology
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Phosphorylation
  • Rabbits
  • Tiopronin / pharmacology

Substances

  • Connexin 43
  • Enzyme Inhibitors
  • Flavonoids
  • Free Radical Scavengers
  • Adenosine Triphosphate
  • Tiopronin
  • Mitogen-Activated Protein Kinase Kinases
  • Diazoxide
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one